カテゴリー： LP Information, 世界, 医療/バイオ

世界の抗消化性潰瘍薬市場予測 2021年-2026年

【英語タイトル】Global Anti Peptic Ulcer Drugs Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9411）・商品コード：LPI21MY9411
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：163
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「抗消化性潰瘍薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、プロトンポンプ阻害剤（PPI）、カリウム競合性酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、抗生物質、潰瘍保護薬など、用途別には、胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD）などにセグメント区分してまとめました。抗消化性潰瘍薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・抗消化性潰瘍薬の世界市場概要（サマリー）
・抗消化性潰瘍薬の企業別販売量・売上
・抗消化性潰瘍薬の企業別市場シェア
・抗消化性潰瘍薬の世界市場規模 2016年-2021年：種類別（プロトンポンプ阻害剤（PPI）、カリウム競合性酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、抗生物質、潰瘍保護薬）
・抗消化性潰瘍薬の世界市場規模 2016年-2021年：用途別（胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD））
・抗消化性潰瘍薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・抗消化性潰瘍薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・抗消化性潰瘍薬のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・抗消化性潰瘍薬の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・抗消化性潰瘍薬市場の成長要因・課題・動向
・抗消化性潰瘍薬の世界市場予測 2021年-2026年
・抗消化性潰瘍薬の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・抗消化性潰瘍薬のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・抗消化性潰瘍薬のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・抗消化性潰瘍薬の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・抗消化性潰瘍薬の世界市場予測：種類別（プロトンポンプ阻害剤（PPI）、カリウム競合性酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、抗生物質、潰瘍保護薬）
・抗消化性潰瘍薬の世界市場予測：用途別（胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD））
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Anti Peptic Ulcer Drugs will have significant change from previous year. By the most conservative estimates of global Anti Peptic Ulcer Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti Peptic Ulcer Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti Peptic Ulcer Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Antibiotics
Ulcer Protective Drugs

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Eisai
Daewoong Pharmaceutical
Takeda Pharmaceutical
HeliCure
AstraZeneca
Ore Pharmaceuticals
Sihuan Pharmaceutical
GlaxoSmithKline
Pfizer
Abbott Laboratories
Yuhan Corporation
Cadila Healthcare
Boehringer Ingelheim

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti Peptic Ulcer Drugs Consumption 2016-2026
2.1.2 Anti Peptic Ulcer Drugs Consumption CAGR by Region
2.2 Anti Peptic Ulcer Drugs Segment by Type
2.2.1 Proton Pump Inhibitors (PPIs)
2.2.2 Potassium-Competitive Acid Blockers (P-CAB)
2.2.3 Antacids
2.2.4 H2 Antagonists
2.2.5 Antibiotics
2.2.6 Ulcer Protective Drugs
2.3 Anti Peptic Ulcer Drugs Sales by Type
2.3.1 Global Anti Peptic Ulcer Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Anti Peptic Ulcer Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Anti Peptic Ulcer Drugs Sale Price by Type (2016-2021)
2.4 Anti Peptic Ulcer Drugs Segment by Application
2.4.1 Gastritis
2.4.2 Gastric Ulcers
2.4.3 Duodenal Ulcers
2.4.4 Gastroesophageal Reflux Disease (GERD)
2.5 Anti Peptic Ulcer Drugs Sales by Application
2.5.1 Global Anti Peptic Ulcer Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Anti Peptic Ulcer Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Anti Peptic Ulcer Drugs Sale Price by Application (2016-2021)

3 Global Anti Peptic Ulcer Drugs by Company
3.1 Global Anti Peptic Ulcer Drugs Sales Market Share by Company
3.1.1 Global Anti Peptic Ulcer Drugs Sales by Company (2019-2021)
3.1.2 Global Anti Peptic Ulcer Drugs Sales Market Share by Company (2019-2021)
3.2 Global Anti Peptic Ulcer Drugs Revenue Market Share by Company
3.2.1 Global Anti Peptic Ulcer Drugs Revenue by Company (2019-2021)
3.2.2 Global Anti Peptic Ulcer Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Anti Peptic Ulcer Drugs Sale Price by Company
3.4 Global Manufacturers Anti Peptic Ulcer Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti Peptic Ulcer Drugs Product Location Distribution
3.4.2 Players Anti Peptic Ulcer Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Anti Peptic Ulcer Drugs by Region
4.1 Global Anti Peptic Ulcer Drugs by Region
4.1.1 Global Anti Peptic Ulcer Drugs Sales by Region
4.1.2 Global Anti Peptic Ulcer Drugs Revenue by Region
4.2 Americas Anti Peptic Ulcer Drugs Sales Growth
4.3 APAC Anti Peptic Ulcer Drugs Sales Growth
4.4 Europe Anti Peptic Ulcer Drugs Sales Growth
4.5 Middle East & Africa Anti Peptic Ulcer Drugs Sales Growth

5 Americas
5.1 Americas Anti Peptic Ulcer Drugs Sales by Country
5.1.1 Americas Anti Peptic Ulcer Drugs Sales by Country (2016-2021)
5.1.2 Americas Anti Peptic Ulcer Drugs Revenue by Country (2016-2021)
5.2 Americas Anti Peptic Ulcer Drugs Sales by Type
5.3 Americas Anti Peptic Ulcer Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Anti Peptic Ulcer Drugs Sales by Region
6.1.1 APAC Anti Peptic Ulcer Drugs Sales by Region (2016-2021)
6.1.2 APAC Anti Peptic Ulcer Drugs Revenue by Region (2016-2021)
6.2 APAC Anti Peptic Ulcer Drugs Sales by Type
6.3 APAC Anti Peptic Ulcer Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Anti Peptic Ulcer Drugs by Country
7.1.1 Europe Anti Peptic Ulcer Drugs Sales by Country (2016-2021)
7.1.2 Europe Anti Peptic Ulcer Drugs Revenue by Country (2016-2021)
7.2 Europe Anti Peptic Ulcer Drugs Sales by Type
7.3 Europe Anti Peptic Ulcer Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Anti Peptic Ulcer Drugs by Country
8.1.1 Middle East & Africa Anti Peptic Ulcer Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Anti Peptic Ulcer Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Anti Peptic Ulcer Drugs Sales by Type
8.3 Middle East & Africa Anti Peptic Ulcer Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Anti Peptic Ulcer Drugs Distributors
10.3 Anti Peptic Ulcer Drugs Customer

11 Global Anti Peptic Ulcer Drugs Market Forecast
11.1 Global Anti Peptic Ulcer Drugs Forecast by Region
11.1.1 Global Anti Peptic Ulcer Drugs Forecast by Regions (2021-2026)
11.2.2 Global Anti Peptic Ulcer Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Anti Peptic Ulcer Drugs Forecast by Type
11.7 Global Anti Peptic Ulcer Drugs Forecast by Application

12 Key Players Analysis
12.1 Eisai
12.1.1 Eisai Eisai Company Information
12.1.2 Eisai Anti Peptic Ulcer Drugs Product Offered
12.1.3 Eisai Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Eisai Main Business Overview
12.1.5 Eisai Latest Developments
12.2 Daewoong Pharmaceutical
12.2.1 Daewoong Pharmaceutical Company Information
12.2.2 Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Product Offered
12.2.3 Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Daewoong Pharmaceutical Main Business Overview
12.2.5 Daewoong Pharmaceutical Latest Developments
12.3 Takeda Pharmaceutical
12.3.1 Takeda Pharmaceutical Company Information
12.3.2 Takeda Pharmaceutical Anti Peptic Ulcer Drugs Product Offered
12.3.3 Takeda Pharmaceutical Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Takeda Pharmaceutical Main Business Overview
12.3.5 Takeda Pharmaceutical Latest Developments
12.4 HeliCure
12.4.1 HeliCure Company Information
12.4.2 HeliCure Anti Peptic Ulcer Drugs Product Offered
12.4.3 HeliCure Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 HeliCure Main Business Overview
12.4.5 HeliCure Latest Developments
12.5 AstraZeneca
12.5.1 AstraZeneca Company Information
12.5.2 AstraZeneca Anti Peptic Ulcer Drugs Product Offered
12.5.3 AstraZeneca Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 AstraZeneca Main Business Overview
12.5.5 AstraZeneca Latest Developments
12.6 Ore Pharmaceuticals
12.6.1 Ore Pharmaceuticals Company Information
12.6.2 Ore Pharmaceuticals Anti Peptic Ulcer Drugs Product Offered
12.6.3 Ore Pharmaceuticals Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Ore Pharmaceuticals Main Business Overview
12.6.5 Ore Pharmaceuticals Latest Developments
12.7 Sihuan Pharmaceutical
12.7.1 Sihuan Pharmaceutical Company Information
12.7.2 Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Product Offered
12.7.3 Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Sihuan Pharmaceutical Main Business Overview
12.7.5 Sihuan Pharmaceutical Latest Developments
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Company Information
12.8.2 GlaxoSmithKline Anti Peptic Ulcer Drugs Product Offered
12.8.3 GlaxoSmithKline Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 GlaxoSmithKline Main Business Overview
12.8.5 GlaxoSmithKline Latest Developments
12.9 Pfizer
12.9.1 Pfizer Company Information
12.9.2 Pfizer Anti Peptic Ulcer Drugs Product Offered
12.9.3 Pfizer Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Pfizer Main Business Overview
12.9.5 Pfizer Latest Developments
12.10 Abbott Laboratories
12.10.1 Abbott Laboratories Company Information
12.10.2 Abbott Laboratories Anti Peptic Ulcer Drugs Product Offered
12.10.3 Abbott Laboratories Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Abbott Laboratories Main Business Overview
12.10.5 Abbott Laboratories Latest Developments
12.11 Yuhan Corporation
12.11.1 Yuhan Corporation Company Information
12.11.2 Yuhan Corporation Anti Peptic Ulcer Drugs Product Offered
12.11.3 Yuhan Corporation Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Yuhan Corporation Main Business Overview
12.11.5 Yuhan Corporation Latest Developments
12.12 Cadila Healthcare
12.12.1 Cadila Healthcare Company Information
12.12.2 Cadila Healthcare Anti Peptic Ulcer Drugs Product Offered
12.12.3 Cadila Healthcare Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Cadila Healthcare Main Business Overview
12.12.5 Cadila Healthcare Latest Developments
12.13 Boehringer Ingelheim
12.13.1 Boehringer Ingelheim Company Information
12.13.2 Boehringer Ingelheim Anti Peptic Ulcer Drugs Product Offered
12.13.3 Boehringer Ingelheim Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Boehringer Ingelheim Main Business Overview
12.13.5 Boehringer Ingelheim Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Anti Peptic Ulcer Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Proton Pump Inhibitors (PPIs)
Table 3. Major Players of Potassium-Competitive Acid Blockers (P-CAB)
Table 4. Major Players of Antacids
Table 5. Major Players of H2 Antagonists
Table 6. Major Players of Antibiotics
Table 7. Major Players of Ulcer Protective Drugs
Table 8. Global Anti Peptic Ulcer Drugs Sales by Type (2016-2021) & (K Units)
Table 9. Global Anti Peptic Ulcer Drugs Sales Market Share by Type (2016-2021)
Table 10. Global Anti Peptic Ulcer Drugs Revenue by Type (2016-2021) & ($ million)
Table 11. Global Anti Peptic Ulcer Drugs Revenue Market Share by Type (2016-2021)
Table 12. Global Anti Peptic Ulcer Drugs Sale Price by Type (2016-2021)
Table 13. Global Anti Peptic Ulcer Drugs Sales by Application (2016-2021) & (K Units)
Table 14. Global Anti Peptic Ulcer Drugs Sales Market Share by Application (2016-2021)
Table 15. Global Anti Peptic Ulcer Drugs Value by Application (2016-2021)
Table 16. Global Anti Peptic Ulcer Drugs Revenue Market Share by Application (2016-2021)
Table 17. Global Anti Peptic Ulcer Drugs Sale Price by Application (2016-2021)
Table 18. Global Anti Peptic Ulcer Drugs Sales by Company (2019-2021) & (K Units)
Table 19. Global Anti Peptic Ulcer Drugs Sales Market Share by Company (2019-2021)
Table 20. Global Anti Peptic Ulcer Drugs Revenue by Company (2019-2021) ($ Millions)
Table 21. Global Anti Peptic Ulcer Drugs Revenue Market Share by Company (2019-2021)
Table 22. Global Anti Peptic Ulcer Drugs Sale Price by Company (2019-2021)
Table 23. Key Manufacturers Anti Peptic Ulcer Drugs Producing Area Distribution and Sales Area
Table 24. Players Anti Peptic Ulcer Drugs Products Offered
Table 25. Anti Peptic Ulcer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Anti Peptic Ulcer Drugs Sales by Region (2016-2021) (K Units)
Table 29. Global Anti Peptic Ulcer Drugs Sales Market Share by Region (2016-2021)
Table 30. Global Anti Peptic Ulcer Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 31. Global Anti Peptic Ulcer Drugs Revenue Market Share by Region (2016-2021)
Table 32. Americas Anti Peptic Ulcer Drugs Sales by Country (2016-2021) & (K Units)
Table 33. Americas Anti Peptic Ulcer Drugs Sales Market Share by Country (2016-2021)
Table 34. Americas Anti Peptic Ulcer Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 35. Americas Anti Peptic Ulcer Drugs Revenue Market Share by Country (2016-2021)
Table 36. Americas Anti Peptic Ulcer Drugs Sales by Type (2016-2021) & (K Units)
Table 37. Americas Anti Peptic Ulcer Drugs Sales Market Share by Type (2016-2021)
Table 38. Americas Anti Peptic Ulcer Drugs Sales by Application (2016-2021) & (K Units)
Table 39. Americas Anti Peptic Ulcer Drugs Sales Market Share by Application (2016-2021)
Table 40. APAC Anti Peptic Ulcer Drugs Sales by Region (2016-2021) & (K Units)
Table 41. APAC Anti Peptic Ulcer Drugs Sales Market Share by Region (2016-2021)
Table 42. APAC Anti Peptic Ulcer Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 43. APAC Anti Peptic Ulcer Drugs Revenue Market Share by Region (2016-2021)
Table 44. APAC Anti Peptic Ulcer Drugs Sales by Type (2016-2021) & (K Units)
Table 45. APAC Anti Peptic Ulcer Drugs Sales Market Share by Type (2016-2021)
Table 46. APAC Anti Peptic Ulcer Drugs Sales by Application (2016-2021) & (K Units)
Table 47. APAC Anti Peptic Ulcer Drugs Sales Market Share by Application (2016-2021)
Table 48. Europe Anti Peptic Ulcer Drugs Sales by Country (2016-2021) & (K Units)
Table 49. Europe Anti Peptic Ulcer Drugs Sales Market Share by Country (2016-2021)
Table 50. Europe Anti Peptic Ulcer Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 51. Europe Anti Peptic Ulcer Drugs Revenue Market Share by Country (2016-2021)
Table 52. Europe Anti Peptic Ulcer Drugs Sales by Type (2016-2021) & (K Units)
Table 53. Europe Anti Peptic Ulcer Drugs Sales Market Share by Type (2016-2021)
Table 54. Europe Anti Peptic Ulcer Drugs Sales by Application (2016-2021) & (K Units)
Table 55. Europe Anti Peptic Ulcer Drugs Sales Market Share by Application (2016-2021)
Table 56. Middle East & Africa Anti Peptic Ulcer Drugs Sales by Country (2016-2021) & (K Units)
Table 57. Middle East & Africa Anti Peptic Ulcer Drugs Sales Market Share by Country (2016-2021)
Table 58. Middle East & Africa Anti Peptic Ulcer Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 59. Middle East & Africa Anti Peptic Ulcer Drugs Revenue Market Share by Country (2016-2021)
Table 60. Middle East & Africa Anti Peptic Ulcer Drugs Sales by Type (2016-2021) & (K Units)
Table 61. Middle East & Africa Anti Peptic Ulcer Drugs Sales Market Share by Type (2016-2021)
Table 62. Middle East & Africa Anti Peptic Ulcer Drugs Sales by Application (2016-2021) & (K Units)
Table 63. Middle East & Africa Anti Peptic Ulcer Drugs Sales Market Share by Application (2016-2021)
Table 64. Global Anti Peptic Ulcer Drugs Sales Forecast by Type (2021-2026) & (K Units)
Table 65. Global Anti Peptic Ulcer Drugs Sales Market Share Forecast by Type (2021-2026)
Table 66. Global Anti Peptic Ulcer Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 67. Global Anti Peptic Ulcer Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 68. Global Anti Peptic Ulcer Drugs Sales Forecast by Application (2021-2026) & (K Units)
Table 69. Global Anti Peptic Ulcer Drugs Sales Market Share Forecast by Application (2021-2026)
Table 70. Global Anti Peptic Ulcer Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 71. Global Anti Peptic Ulcer Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 72. Eisai Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Eisai Anti Peptic Ulcer Drugs Product Offered
Table 74. Eisai Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 75. Eisai Main Business
Table 76. Eisai Latest Developments
Table 77. Daewoong Pharmaceutical Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Product Offered
Table 79. Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 80. Daewoong Pharmaceutical Main Business
Table 81. Daewoong Pharmaceutical Latest Developments
Table 82. Takeda Pharmaceutical Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Takeda Pharmaceutical Anti Peptic Ulcer Drugs Product Offered
Table 84. Takeda Pharmaceutical Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 85. Takeda Pharmaceutical Main Business
Table 86. Takeda Pharmaceutical Latest Developments
Table 87. HeliCure Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. HeliCure Anti Peptic Ulcer Drugs Product Offered
Table 89. HeliCure Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 90. HeliCure Main Business
Table 91. HeliCure Latest Developments
Table 92. AstraZeneca Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. AstraZeneca Anti Peptic Ulcer Drugs Product Offered
Table 94. AstraZeneca Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 95. AstraZeneca Main Business
Table 96. AstraZeneca Latest Developments
Table 97. Ore Pharmaceuticals Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Ore Pharmaceuticals Anti Peptic Ulcer Drugs Product Offered
Table 99. Ore Pharmaceuticals Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 100. Ore Pharmaceuticals Main Business
Table 101. Ore Pharmaceuticals Latest Developments
Table 102. Sihuan Pharmaceutical Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Product Offered
Table 104. Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 105. Sihuan Pharmaceutical Main Business
Table 106. Sihuan Pharmaceutical Latest Developments
Table 107. GlaxoSmithKline Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. GlaxoSmithKline Anti Peptic Ulcer Drugs Product Offered
Table 109. GlaxoSmithKline Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 110. GlaxoSmithKline Main Business
Table 111. GlaxoSmithKline Latest Developments
Table 112. Pfizer Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Pfizer Anti Peptic Ulcer Drugs Product Offered
Table 114. Pfizer Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 115. Pfizer Main Business
Table 116. Pfizer Latest Developments
Table 117. Abbott Laboratories Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Abbott Laboratories Anti Peptic Ulcer Drugs Product Offered
Table 119. Abbott Laboratories Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 120. Abbott Laboratories Main Business
Table 121. Abbott Laboratories Latest Developments
Table 122. Yuhan Corporation Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Yuhan Corporation Anti Peptic Ulcer Drugs Product Offered
Table 124. Yuhan Corporation Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 125. Yuhan Corporation Main Business
Table 126. Yuhan Corporation Latest Developments
Table 127. Cadila Healthcare Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Cadila Healthcare Anti Peptic Ulcer Drugs Product Offered
Table 129. Cadila Healthcare Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 130. Cadila Healthcare Main Business
Table 131. Cadila Healthcare Latest Developments
Table 132. Boehringer Ingelheim Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Boehringer Ingelheim Anti Peptic Ulcer Drugs Product Offered
Table 134. Boehringer Ingelheim Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 135. Boehringer Ingelheim Main Business
Table 136. Boehringer Ingelheim Latest Developments
List of Figures
Figure 1. Picture of Anti Peptic Ulcer Drugs
Figure 2. Anti Peptic Ulcer Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti Peptic Ulcer Drugs Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Anti Peptic Ulcer Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Anti Peptic Ulcer Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Proton Pump Inhibitors (PPIs)
Figure 10. Product Picture of Potassium-Competitive Acid Blockers (P-CAB)
Figure 11. Product Picture of Antacids
Figure 12. Product Picture of H2 Antagonists
Figure 13. Product Picture of Antibiotics
Figure 14. Product Picture of Ulcer Protective Drugs
Figure 15. Global Anti Peptic Ulcer Drugs Sales Market Share by Type in 2020
Figure 16. Global Anti Peptic Ulcer Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Anti Peptic Ulcer Drugs Consumed in Gastritis
Figure 18. Global Anti Peptic Ulcer Drugs Market: Gastritis (2016-2021) & (K Units)
Figure 19. Anti Peptic Ulcer Drugs Consumed in Gastric Ulcers
Figure 20. Global Anti Peptic Ulcer Drugs Market: Gastric Ulcers (2016-2021) & (K Units)
Figure 21. Anti Peptic Ulcer Drugs Consumed in Duodenal Ulcers
Figure 22. Global Anti Peptic Ulcer Drugs Market: Duodenal Ulcers (2016-2021) & (K Units)
Figure 23. Anti Peptic Ulcer Drugs Consumed in Gastroesophageal Reflux Disease (GERD)
Figure 24. Global Anti Peptic Ulcer Drugs Market: Gastroesophageal Reflux Disease (GERD) (2016-2021) & (K Units)
Figure 25. Global Anti Peptic Ulcer Drugs Sales Market Share by Application (2016-2021)
Figure 26. Global Anti Peptic Ulcer Drugs Revenue Market Share by Application in 2020
Figure 27. Global Anti Peptic Ulcer Drugs Revenue Market by Company in 2020 ($ Million)
Figure 28. Global Anti Peptic Ulcer Drugs Revenue Market Share by Company in 2020
Figure 29. Global Anti Peptic Ulcer Drugs Sales Market Share by Regions (2016-2021)
Figure 30. Global Anti Peptic Ulcer Drugs Revenue Market Share by Region in 2020
Figure 31. Americas Anti Peptic Ulcer Drugs Sales 2016-2021 (K Units)
Figure 32. Americas Anti Peptic Ulcer Drugs Revenue 2016-2021 ($ Millions)
Figure 33. APAC Anti Peptic Ulcer Drugs Sales 2016-2021 (K Units)
Figure 34. APAC Anti Peptic Ulcer Drugs Revenue 2016-2021 ($ Millions)
Figure 35. Europe Anti Peptic Ulcer Drugs Sales 2016-2021 (K Units)
Figure 36. Europe Anti Peptic Ulcer Drugs Revenue 2016-2021 ($ Millions)
Figure 37. Middle East & Africa Anti Peptic Ulcer Drugs Sales 2016-2021 (K Units)
Figure 38. Middle East & Africa Anti Peptic Ulcer Drugs Revenue 2016-2021 ($ Millions)
Figure 39. Americas Anti Peptic Ulcer Drugs Sales Market Share by Country in 2020
Figure 40. Americas Anti Peptic Ulcer Drugs Revenue Market Share by Country in 2020
Figure 41. Americas Anti Peptic Ulcer Drugs Sales Market Share by Type in 2020
Figure 42. Americas Anti Peptic Ulcer Drugs Sales Market Share by Application in 2020
Figure 43. United States Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 44. Canada Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 45. Mexico Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 46. Brazil Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 47. APAC Anti Peptic Ulcer Drugs Sales Market Share by Region in 2020
Figure 48. APAC Anti Peptic Ulcer Drugs Revenue Market Share by Regions in 2020
Figure 49. APAC Anti Peptic Ulcer Drugs Sales Market Share by Type in 2020
Figure 50. APAC Anti Peptic Ulcer Drugs Sales Market Share by Application in 2020
Figure 51. China Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 52. Japan Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 53. Korea Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 54. Southeast Asia Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 55. India Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 56. Australia Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. Europe Anti Peptic Ulcer Drugs Sales Market Share by Country in 2020
Figure 58. Europe Anti Peptic Ulcer Drugs Revenue Market Share by Country in 2020
Figure 59. Europe Anti Peptic Ulcer Drugs Sales Market Share by Type in 2020
Figure 60. Europe Anti Peptic Ulcer Drugs Sales Market Share by Application in 2020
Figure 61. Germany Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 62. France Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 63. UK Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 64. Italy Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 65. Russia Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 66. Middle East & Africa Anti Peptic Ulcer Drugs Sales Market Share by Country in 2020
Figure 67. Middle East & Africa Anti Peptic Ulcer Drugs Revenue Market Share by Country in 2020
Figure 68. Middle East & Africa Anti Peptic Ulcer Drugs Sales Market Share by Type in 2020
Figure 69. Middle East & Africa Anti Peptic Ulcer Drugs Sales Market Share by Application in 2020
Figure 70. Egypt Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 71. South Africa Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 72. Israel Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 73. Turkey Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 74. GCC Country Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles


★調査レポート[世界の抗消化性潰瘍薬市場予測 2021年-2026年] (コード：LPI21MY9411)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の抗消化性潰瘍薬市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の降圧薬市場予測 2021年-2026年
    LPI21MY9420 / LP Information / 2021年5月 / LPインフォメーション社の「降圧薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、カルシウムチャネル遮断薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬など、用途別には、病院薬局、小売薬局、オンライン薬局などにセグメント区分してまとめました。降圧薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・降圧薬の世界市場概要（サマリー） ・降圧薬の企業別販売量・売上 ・降圧薬の企業別市場シェア ・降圧薬の世界市場規模 2016年-2021年：種類別（利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、カルシウムチャネル遮断薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬） ・降圧薬の世界市場規模 2016年-2021年：用途別（病院薬局、小売薬局、オンライン薬局） ・降圧薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・降圧薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti-Hypertensive Drugs will have significant change from previous year. By the most conservative estimates of global Anti-Hypertensive Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 39390 million in 2019. Over the next five years the Anti-Hypertensive Drugs market will register a 1.7% CAGR in terms of revenue, the global market size will reach US$ 42110 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Hypertensive Drugs market by product type, application, key manufacturers and...
  • 世界の抗片頭痛薬市場予測 2021年-2026年
    LPI21MY9422 / LP Information / 2021年5月 / LPインフォメーション社の「抗片頭痛薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、トリプタン、麦角、その他など、用途別には、女性、男性などにセグメント区分してまとめました。抗片頭痛薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗片頭痛薬の世界市場概要（サマリー） ・抗片頭痛薬の企業別販売量・売上 ・抗片頭痛薬の企業別市場シェア ・抗片頭痛薬の世界市場規模 2016年-2021年：種類別（トリプタン、麦角、その他） ・抗片頭痛薬の世界市場規模 2016年-2021年：用途別（女性、男性） ・抗片頭痛薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗片頭痛薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti-Migraine Drugs will have significant change from previous year. By the most conservative estimates of global Anti-Migraine Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti-Migraine Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Migraine Drugs market by product type, application, key manufacturers and...
  • 世界の抗肥満薬市場予測 2021年-2026年
    LPI21MY9410 / LP Information / 2021年5月 / LPインフォメーション社の「抗肥満薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、経口薬、ダイエットパッチ、その他など、用途別には、男性、女性などにセグメント区分してまとめました。抗肥満薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗肥満薬の世界市場概要（サマリー） ・抗肥満薬の企業別販売量・売上 ・抗肥満薬の企業別市場シェア ・抗肥満薬の世界市場規模 2016年-2021年：種類別（経口薬、ダイエットパッチ、その他） ・抗肥満薬の世界市場規模 2016年-2021年：用途別（男性、女性） ・抗肥満薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗肥満薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti Obesity Drugs will have significant change from previous year. By the most conservative estimates of global Anti Obesity Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti Obesity Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti Obesity Drugs market by product type,...
  • 世界の抗感染API市場予測 2021年-2026年
    LPI21MY0707 / LP Information / 2021年5月 / LPインフォメーション社の「抗感染APIの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、β-ラクタム薬、マクロライド系抗生物質、カルバペネム系抗生物質、キノロン系抗生物質など、用途別には、全身用抗菌薬、全身用抗ウイルス薬、全身用抗原、細菌、免疫血清・免疫グロブリン、抗酸菌薬、ワクチン、その他などにセグメント区分してまとめました。抗感染APIのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗感染APIの世界市場概要（サマリー） ・抗感染APIの企業別販売量・売上 ・抗感染APIの企業別市場シェア ・抗感染APIの世界市場規模 2016年-2021年：種類別（β-ラクタム薬、マクロライド系抗生物質、カルバペネム系抗生物質、キノロン系抗生物質） ・抗感染APIの世界市場規模 2016年-2021年：用途別（全身用抗菌薬、全身用抗ウイルス薬、全身用抗原、細菌、免疫血清・免疫グロブリン、抗酸菌薬、ワクチン、その他） ・抗感染APIの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗感染APIのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Anti-infective API will have significant change from previous year. By the most conservative estimates of global Anti-infective API market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Anti-infective API market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-infective API market by product type, application, key manufacturers and...
  • 世界のジョサマイシン薬市場予測 2021年-2026年
    LPI21MY9651 / LP Information / 2021年5月 / LPインフォメーション社の「ジョサマイシン薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ジョサマイシン錠、ジョサマイシンプロピオン酸顆粒など、用途別には、病院薬局、小売ドラッグストアなどにセグメント区分してまとめました。ジョサマイシン薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ジョサマイシン薬の世界市場概要（サマリー） ・ジョサマイシン薬の企業別販売量・売上 ・ジョサマイシン薬の企業別市場シェア ・ジョサマイシン薬の世界市場規模 2016年-2021年：種類別（ジョサマイシン錠、ジョサマイシンプロピオン酸顆粒） ・ジョサマイシン薬の世界市場規模 2016年-2021年：用途別（病院薬局、小売ドラッグストア） ・ジョサマイシン薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ジョサマイシン薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Josamycin Drugs will have significant change from previous year. By the most conservative estimates of global Josamycin Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Josamycin Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Josamycin Drugs market by product type, application, key manufacturers and...
  • 世界のCD38モノクローナル抗体薬市場予測 2021年-2026年
    LPI21MY9468 / LP Information / 2021年5月 / LPインフォメーション社の「CD38モノクローナル抗体薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ダレツズマブ、イサルツキシマブ、人工毒素体など、用途別には、多発性骨髄腫、びまん性大細胞型B細胞リンパ腫、その他などにセグメント区分してまとめました。CD38モノクローナル抗体薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・CD38モノクローナル抗体薬の世界市場概要（サマリー） ・CD38モノクローナル抗体薬の企業別販売量・売上 ・CD38モノクローナル抗体薬の企業別市場シェア ・CD38モノクローナル抗体薬の世界市場規模 2016年-2021年：種類別（ダレツズマブ、イサルツキシマブ、人工毒素体） ・CD38モノクローナル抗体薬の世界市場規模 2016年-2021年：用途別（多発性骨髄腫、びまん性大細胞型B細胞リンパ腫、その他） ・CD38モノクローナル抗体薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・CD38モノクローナル抗体薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of CD38 Monoclonal Antibody Drugs will have significant change from previous year. By the most conservative estimates of global CD38 Monoclonal Antibody Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the CD38 Monoclonal Antibody Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of CD38 Monoclonal Antibody Drugs...
  • 世界のオキシコドン塩酸塩治療薬市場予測 2021年-2026年
    LPI21MY9614 / LP Information / 2021年5月 / LPインフォメーション社の「オキシコドン塩酸塩治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、錠剤、経口液剤、経口カプセル、静脈内輸液など、用途別には、病院、診療所、その他などにセグメント区分してまとめました。オキシコドン塩酸塩治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・オキシコドン塩酸塩治療薬の世界市場概要（サマリー） ・オキシコドン塩酸塩治療薬の企業別販売量・売上 ・オキシコドン塩酸塩治療薬の企業別市場シェア ・オキシコドン塩酸塩治療薬の世界市場規模 2016年-2021年：種類別（錠剤、経口液剤、経口カプセル、静脈内輸液） ・オキシコドン塩酸塩治療薬の世界市場規模 2016年-2021年：用途別（病院、診療所、その他） ・オキシコドン塩酸塩治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・オキシコドン塩酸塩治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Oxycodone Hydrochloride Drugs will have significant change from previous year. By the most conservative estimates of global Oxycodone Hydrochloride Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Oxycodone Hydrochloride Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Oxycodone Hydrochloride Drugs market by product type,...
  • 世界のイマチニブ薬市場予測 2021年-2026年
    LPI21MY9644 / LP Information / 2021年5月 / LPインフォメーション社の「イマチニブ薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、カプセル、錠剤など、用途別には、病院、ドラッグストア、その他などにセグメント区分してまとめました。イマチニブ薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・イマチニブ薬の世界市場概要（サマリー） ・イマチニブ薬の企業別販売量・売上 ・イマチニブ薬の企業別市場シェア ・イマチニブ薬の世界市場規模 2016年-2021年：種類別（カプセル、錠剤） ・イマチニブ薬の世界市場規模 2016年-2021年：用途別（病院、ドラッグストア、その他） ・イマチニブ薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・イマチニブ薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Imatinib Drugs will have significant change from previous year. By the most conservative estimates of global Imatinib Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Imatinib Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Imatinib Drugs market by product type, application, key manufacturers and...
  • 世界の減量治療薬市場予測 2021年-2026年
    LPI21MY9691 / LP Information / 2021年5月 / LPインフォメーション社の「減量治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、液体、錠剤など、用途別には、軽量化補助、その他などにセグメント区分してまとめました。減量治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・減量治療薬の世界市場概要（サマリー） ・減量治療薬の企業別販売量・売上 ・減量治療薬の企業別市場シェア ・減量治療薬の世界市場規模 2016年-2021年：種類別（液体、錠剤） ・減量治療薬の世界市場規模 2016年-2021年：用途別（軽量化補助、その他） ・減量治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・減量治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Weight Loss Drugs will have significant change from previous year. By the most conservative estimates of global Weight Loss Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Weight Loss Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Weight Loss Drugs market by product type,...
  • 世界の口腔内潰瘍治療薬市場予測 2021年-2026年
    LPI21MY9594 / LP Information / 2021年5月 / LPインフォメーション社の「口腔内潰瘍治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、コルチコステロイド、麻酔薬、鎮痛薬、抗ヒスタミン薬、抗菌薬など、用途別には、口内炎、口腔扁平苔癬、その他などにセグメント区分してまとめました。口腔内潰瘍治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・口腔内潰瘍治療薬の世界市場概要（サマリー） ・口腔内潰瘍治療薬の企業別販売量・売上 ・口腔内潰瘍治療薬の企業別市場シェア ・口腔内潰瘍治療薬の世界市場規模 2016年-2021年：種類別（コルチコステロイド、麻酔薬、鎮痛薬、抗ヒスタミン薬、抗菌薬） ・口腔内潰瘍治療薬の世界市場規模 2016年-2021年：用途別（口内炎、口腔扁平苔癬、その他） ・口腔内潰瘍治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・口腔内潰瘍治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Mouth Ulcers Drugs will have significant change from previous year. By the most conservative estimates of global Mouth Ulcers Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Mouth Ulcers Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Mouth Ulcers Drugs market by product type,...

    • ◆H&Iグローバルリサーチのお客様（例）◆